Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Delgocitinib Cream for Chronic Hand Eczema
Recruiting1 awardPhase 3
Fredericton
This trial is testing if delgocitinib cream is effective at treating chronic hand eczema in children aged 12-17. There will be a range of assessments that rate the severity and extent of CHE symptoms, general health and quality of life.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.